Financial News
Latest News about PFE
Recent news which mentions PFE
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
April 18, 2022
From Benzinga
From Benzinga
Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters
April 18, 2022
Tickers
PFE
From Benzinga
From Benzinga
What Volatility in Novavax Means for Investors
April 18, 2022
From InvestorPlace
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
From Benzinga
Is Novavax Stock a Buy Now?
April 18, 2022
From Motley Fool
3 Winning Stocks to Buy No Matter What the Market Is Doing
April 16, 2022
From Motley Fool
How well is the COVID-19 test-to-treat program working?
April 15, 2022
From MarketWatch
Could Moderna Stock Help You Become a Millionaire?
April 15, 2022
From Motley Fool
Novavax: The Party’s Over
April 15, 2022
From InvestorPlace
Will Novavax Stock Continue to Trend Lower?
April 14, 2022
From InvestorPlace
New York State’s recent COVID case surge caused by two new versions of omicron that are even more infectious than BA.2
April 14, 2022
From MarketWatch
Should You Give Up on Novavax?
April 14, 2022
From Motley Fool
From Benzinga
Pfizer/BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Aged 5-11 Years
April 14, 2022
From Benzinga
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
3 High-Yielding Dividend Stocks to Buy on the Dip
April 13, 2022
From Motley Fool
Here Are 2 Reasons Why Vaccine Stocks Might Cool Off Soon
April 13, 2022
From Motley Fool
3 Things About Moderna That Smart Investors Know
April 13, 2022
From Motley Fool
From Benzinga
From Benzinga
From Motley Fool
Why Myovant Sciences Stock Is Crashing Today
April 12, 2022
From Motley Fool
Novavax Stock Is Slumping: Why Buy the Dip?
April 12, 2022
From InvestorPlace
What's Going On With Myovant Sciences Stock Today?
April 12, 2022
From Benzinga
From Benzinga
From Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.